Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
57,426
+0.88%
|
$8,843,604
$154.59 P/Share
|
|
Sep 21
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.44%
|
$15,153,159
$161.63 P/Share
|
|
Sep 21
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.44%
|
$15,153,159
$161.63 P/Share
|
|
Sep 20
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.46%
|
$14,588,445
$155.14 P/Share
|
|
Sep 20
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.46%
|
$14,588,445
$155.14 P/Share
|
|
Sep 19
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
94,119
+1.49%
|
$14,400,207
$153.48 P/Share
|
|
Sep 19
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
94,119
+1.49%
|
$14,400,207
$153.48 P/Share
|
|
Sep 16
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.01%
|
$9,314,884
$149.58 P/Share
|
|
Sep 16
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.01%
|
$9,314,884
$149.58 P/Share
|
|
Sep 15
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.02%
|
$9,564,948
$153.11 P/Share
|
|
Sep 15
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.02%
|
$9,564,948
$153.11 P/Share
|
|
Sep 14
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.03%
|
$9,502,432
$152.66 P/Share
|
|
Sep 14
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.03%
|
$9,502,432
$152.66 P/Share
|
|
Sep 13
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,516
+1.04%
|
$9,815,012
$157.12 P/Share
|
|
Sep 13
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,516
+1.04%
|
$9,815,012
$157.12 P/Share
|
|
Sep 12
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
62,515
+1.05%
|
$10,440,005
$167.58 P/Share
|
|
Sep 12
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
62,515
+1.05%
|
$10,440,005
$167.58 P/Share
|
|
Sep 09
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.96%
|
$9,275,348
$164.33 P/Share
|
|
Sep 09
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.96%
|
$9,275,348
$164.33 P/Share
|
|
Sep 08
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.97%
|
$8,879,449
$157.65 P/Share
|
|
Sep 08
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.97%
|
$8,879,449
$157.65 P/Share
|
|
Sep 07
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.98%
|
$8,483,550
$150.72 P/Share
|
|
Sep 07
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.98%
|
$8,483,550
$150.72 P/Share
|
|
Sep 06
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
56,557
+0.99%
|
$8,313,879
$147.59 P/Share
|
|
Sep 06
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
56,557
+0.99%
|
$8,313,879
$147.59 P/Share
|
|
Sep 02
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
48,714
+0.86%
|
$7,014,816
$144.98 P/Share
|
|
Sep 02
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
48,714
+0.86%
|
$7,014,816
$144.98 P/Share
|
|
Sep 01
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
42,076
+0.75%
|
$6,058,944
$144.52 P/Share
|
|
Sep 01
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
42,076
+0.75%
|
$6,058,944
$144.52 P/Share
|
|
Jul 18
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
8,330
+0.15%
|
$1,207,850
$145.0 P/Share
|
|
Jul 18
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,330
+0.15%
|
$1,207,850
$145.0 P/Share
|
|
Jul 14
2022
|
August J. Troendle CEO |
BUY
Open market or private purchase
|
Indirect |
22,290
+0.4%
|
$3,209,760
$144.59 P/Share
|
|
Jul 14
2022
|
Medpace Investors, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
22,290
+0.4%
|
$3,209,760
$144.59 P/Share
|
|
May 06
2022
|
Stephen P Ewald General Counsel & Corp. Secy. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.31%
|
$32,000
$32.05 P/Share
|
|
Mar 01
2022
|
August J. Troendle CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+11.03%
|
$9,000,000
$90.65 P/Share
|
|
Feb 23
2022
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
12,400
+38.06%
|
$347,200
$28.32 P/Share
|
|
Feb 17
2022
|
Fred B Davenport Jr Director |
BUY
Open market or private purchase
|
Indirect |
500
+20.0%
|
$72,500
$145.8 P/Share
|
|
Jan 04
2022
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,338
-0.06%
|
$710,994
$213.44 P/Share
|
|
Jan 04
2022
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
3,338
-0.06%
|
$710,994
$213.44 P/Share
|
|
Jan 03
2022
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
19,744
-0.36%
|
$4,185,728
$212.7 P/Share
|
|
Jan 03
2022
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
19,744
-0.36%
|
$4,185,728
$212.7 P/Share
|
|
Dec 31
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,069
-0.24%
|
$2,862,111
$219.14 P/Share
|
|
Dec 31
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
13,069
-0.24%
|
$2,862,111
$219.14 P/Share
|
|
Dec 30
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
17,376
-0.31%
|
$3,822,720
$220.34 P/Share
|
|
Dec 30
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
17,376
-0.31%
|
$3,822,720
$220.34 P/Share
|
|
Dec 29
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
16,750
-0.3%
|
$3,685,000
$220.16 P/Share
|
|
Dec 29
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
16,750
-0.3%
|
$3,685,000
$220.16 P/Share
|
|
Dec 28
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,118
-0.43%
|
$5,354,196
$222.18 P/Share
|
|
Dec 28
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
24,118
-0.43%
|
$5,354,196
$222.18 P/Share
|
|
Dec 27
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
39,171
-0.7%
|
$8,852,646
$226.11 P/Share
|